Previous studies have shown that NLRP3 inhibition (68) reduces MDSC infiltration into the tumor suggesting an additional mechanism for how CX3CR1 mAb blockade can reduce tumor immune evasion. The gene discussed is NLRP3; the disease is neoplasm.